November 10, 2016 Comments Off on Kyle Bass: The U.S. Still Has A Drug Problem Posted in: General Biotechnology To date, the Patent Trial and Appeal Board has reached a final decision in eight instituted inter partes review (IPR) challenges, including seven IPRs filed by the Coalition for Affordable Drugs and one IPR filed by Erich Spangenberg and me personally on a not-for-profit basis. The outcomes were favorable in seven of the eight IPRs. […]
November 1, 2016 Comments Off on Americans say lowering drug costs is a top priority Posted in: General Biotechnology And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is highlighted by a significant milestone for our shortest person, who turns another page in the book of life. And so, we will […]